Eltek Ltd. recently announced its financial results for the second quarter of 2025, reporting a 20% increase in revenues, reaching $12.5 million compared to $10.5 million in the same quarter of 2024. The company also achieved a significant improvement in its gross margin, which expanded to 24.1% from 15.6% the previous year. Operating income saw a remarkable increase of 259%, rising to $1.5 million from $0.4 million in the second quarter of 2024. Despite these positive developments, Eltek reported a decrease in net income for the quarter, which was $0.4 million, or $0.05 per fully diluted share, down from $0.8 million, or $0.11 per fully diluted share, in the same period of the previous year. This decline was primarily attributed to financial expenses of $1.0 million, a shift from financial income of $0.5 million in the second quarter of 2024, largely due to the erosion of the U.S. dollar against the NIS. For the first six months of 2025, Eltek's revenues totaled $25.3 million, an increase from $22.2 million in the same period of 2024. The net profit for the six months was $1.4 million, or $0.20 per fully diluted share, compared to $2.5 million, or $0.38 per fully diluted share, in the first half of 2024. CEO Eli Yaffe highlighted the strong momentum in the defense and medical segments as key drivers of these results.